3fq9: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
'''Unreleased structure'''
{{Seed}}
[[Image:3fq9.jpg|left|200px]]


The entry 3fq9 is ON HOLD until Paper Publication
<!--
The line below this paragraph, containing "STRUCTURE_3fq9", creates the "Structure Box" on the page.
You may change the PDB parameter (which sets the PDB file loaded into the applet)
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
or leave the SCENE parameter empty for the default display.
-->
{{STRUCTURE_3fq9|  PDB=3fq9  |  SCENE=  }}


Authors: Zhao, M., Wan, Z.L., Whittaker, L., Xu, B., Phillips, N., Katsoyannis, P., Whittaker, J., Weiss, M.A.
===Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications===


Description: Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 1 08:53:56 2009''
==About this Structure==
3FQ9 is a 4 chains structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3FQ9 OCA].
[[Category: Katsoyannis, P.]]
[[Category: Phillips, N.]]
[[Category: Wan, Z L.]]
[[Category: Weiss, M A.]]
[[Category: Whittaker, J.]]
[[Category: Whittaker, L.]]
[[Category: Xu, B.]]
[[Category: Zhao, M.]]
[[Category: Carbohydrate metabolism]]
[[Category: Cleavage on pair of basic residue]]
[[Category: Diabetes mellitus]]
[[Category: Disease mutation]]
[[Category: Glucose metabolism]]
[[Category: Hormone]]
[[Category: Insulin design]]
[[Category: Pharmaceutical]]
[[Category: Rational]]
[[Category: Receptor-binding]]
[[Category: Secreted]]
[[Category: Structure]]
[[Category: Therapeutic implication]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Aug 5 10:55:03 2009''

Revision as of 10:55, 5 August 2009

File:3fq9.jpg

Template:STRUCTURE 3fq9

Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implicationsDesign of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and therapeutic implications

About this StructureAbout this Structure

3FQ9 is a 4 chains structure. Full crystallographic information is available from OCA.

Page seeded by OCA on Wed Aug 5 10:55:03 2009

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA